104 results
Page 4 of 6
425
EX-99.1
l8x23
23 Jul 08
Business combination disclosure
12:00am
6-K
EX-2
4agwddbu2 n8xcmfcos
18 Jul 08
Report of Foreign Private Issuer
12:00am
425
EX-2.1
fhhcgpm
18 Jul 08
Business combination disclosure
12:00am
6-K
ma6k wrudb9qi0m8fp
12 May 08
Teva to Present at the Bank of America Health Care Conference
12:00am
6-K
mdphe0o rt0wn71yvk
13 Feb 07
Teva Reports Fourth Quarter and Full Year 2006 Results
12:00am
6-K
f7obvcosq 74qoj6
13 Nov 06
Current report (foreign)
12:00am
6-K
s5pwed
14 Aug 06
Current report (foreign)
12:00am
6-K
cnfvc5p tqyldz
27 Jul 06
Teva Initiates Phase III Study to Confirm Increased Efficacy of Higher Dose of Glatiramer Acetate for the Treatment of Relapsing-remitting Multiple Sclerosis
12:00am
6-K
1nj1l rohjk3ad
15 May 06
Current report (foreign)
12:00am
6-K
k9mfk a1r
6 Apr 06
Notice of Annual Meeting of Shareholders - Amendment
12:00am
6-K
jdjjyk56s u8o1nm
3 Apr 06
Proxy Statement
12:00am
6-K
3f5g4twoi
28 Feb 06
Teva Reports Record Sales and Net Income for the Fourth Quarter and Full Year 2005
12:00am
424B5
cnjgvykjzoh yom
30 Jan 06
Prospectus supplement for primary offering
12:00am
424B5
134jo0uhqhh6 qxn
30 Jan 06
Prospectus supplement for primary offering
12:00am
424B5
f76od7z3m2d2id
30 Jan 06
Prospectus supplement for primary offering
12:00am
F-3ASR
u2aw23chsprg3k5y4mz
30 Jan 06
Automatic shelf registration (foreign)
12:00am
424B5
9eo0be3
26 Jan 06
Prospectus supplement for primary offering
12:00am
424B5
k9yp0llfxq6cdynvw5b
26 Jan 06
Prospectus supplement for primary offering
12:00am